By staff writers
March 4, 2018

French contrast developer Guerbet is featuring its new Contrast&Care contrast media management software at ECR 2018 in Vienna.

Contrast&Care is a contrast media injection management software for medical imaging centers. It combines all the information on injections, such as the contrast media used, injection protocols, and patient data, during medical imaging examinations and interfaces with imaging informatics systems such as RIS and PACS networks. Information generated by injectors is transmitted to Contrast&Care after each exam, enabling users to view the history of each patient, as well as the exams with contrast that have been performed and the doses of contrast media administered.

Contrast&Care also gives users the option of reviewing and creating libraries for contrast protocols, in addition to viewing statistics and trends related to injection activity and the use of contrast media.

Contrast&Care complements Dose&Care in Guerbet's portfolio of contrast software.

Guerbet highlights revenue growth for Q4, 2017
French contrast developer Guerbet posted revenue increases for its 2017 fourth quarter and year-end (end-December 31).
Guerbet launches contrast management software
French contrast developer Guerbet plans to launch a new contrast management software offering called Contrast&Care at the RSNA 2017 conference.
Guerbet posts revenue growth for Q3
Contrast agent manufacturer Guerbet posted revenue increases for the third-quarter and nine-month periods of its fiscal 2017.
Guerbet issues statement on FDA gadolinium vote
Contrast agent manufacturer Guerbet has issued a statement regarding gadolinium retention from MRI contrast media following today's meeting of the U.S....
Guerbet lands expanded FDA clearance for Dotarem
French contrast developer Guerbet said the U.S. Food and Drug Administration (FDA) has approved its Dotarem gadolinium-based MRI contrast agent for use...

Copyright © 2018

Last Updated hh 3/5/2018 2:46:27 AM